As of 2025-07-11, the Relative Valuation of Biomarin Pharmaceutical Inc (BMRN) is 63.56 USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.82 USD, the upside of Biomarin Pharmaceutical Inc based on Relative Valuation is 8.1%.
The range of the Relative Valuation is 49.79 - 74.41 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.3x - 24.7x | 22.2x |
| Forward P/E multiples | 16.7x - 25.0x | 22.2x |
| Fair Price | 49.79 - 74.41 | 63.56 |
| Upside | -15.4% - 26.5% | 8.1% |
| Date | P/E |
| 2025-07-10 | 21.53 |
| 2025-07-09 | 21.84 |
| 2025-07-08 | 21.23 |
| 2025-07-07 | 21.02 |
| 2025-07-03 | 21.05 |
| 2025-07-02 | 20.93 |
| 2025-07-01 | 20.57 |
| 2025-06-30 | 20.12 |
| 2025-06-27 | 20.20 |
| 2025-06-26 | 19.80 |
| 2025-06-25 | 19.82 |
| 2025-06-24 | 20.02 |
| 2025-06-23 | 19.80 |
| 2025-06-20 | 20.13 |
| 2025-06-18 | 20.22 |
| 2025-06-17 | 20.13 |
| 2025-06-16 | 20.59 |
| 2025-06-13 | 20.58 |
| 2025-06-12 | 20.97 |
| 2025-06-11 | 20.92 |
| 2025-06-10 | 21.04 |
| 2025-06-09 | 20.82 |
| 2025-06-06 | 20.74 |
| 2025-06-05 | 20.23 |
| 2025-06-04 | 20.54 |
| 2025-06-03 | 20.79 |
| 2025-06-02 | 20.88 |
| 2025-05-30 | 21.26 |
| 2025-05-29 | 21.43 |
| 2025-05-28 | 21.27 |
| 2025-05-27 | 21.27 |
| 2025-05-23 | 21.07 |
| 2025-05-22 | 21.24 |
| 2025-05-21 | 21.41 |
| 2025-05-20 | 21.94 |
| 2025-05-19 | 21.75 |
| 2025-05-16 | 21.70 |
| 2025-05-15 | 21.33 |
| 2025-05-14 | 21.49 |
| 2025-05-13 | 21.88 |
| 2025-05-12 | 22.47 |
| 2025-05-09 | 21.55 |
| 2025-05-08 | 21.90 |
| 2025-05-07 | 21.72 |
| 2025-05-06 | 21.83 |
| 2025-05-05 | 22.72 |
| 2025-05-02 | 22.71 |
| 2025-05-01 | 22.96 |
| 2025-04-30 | 23.32 |
| 2025-04-29 | 23.17 |